Cybin (HELP) Assets (2021 - 2025)
Cybin (HELP) reported Assets of $180.2 million for Q1 2025, down 19.59% on a YoY basis from $224.1 million in Q1 2024, and down 0.7% quarter-over-quarter from $181.5 million in Q4 2024.
Cybin (HELP) Assets (2021 - 2025) Analysis & Trends
Cybin has reported Assets for 5 years, with the latest figure at $180.2 million in Q1 2025.
- For the quarter ending Q1 2025, Assets fell 19.59% year-over-year to $180.2 million; the trailing twelve-month figure through Jun 2025 stood at $180.2 million (down 13.4% YoY), and the FY2025 full-year result was $186.0 million, down 17.0% from the prior year.
- Assets for Q1 2025 stood at $180.2 million, down from $181.5 million in the prior quarter.
- The five-year high for Assets was $224.1 million in Q1 2024, with the low at $33.8 million in Q1 2023.
- Historically, Assets has averaged $107.5 million across 5 years, with a median of $75.5 million in 2021.
- Annual changes were most pronounced in 2022 — Assets plunged 40.77% — and 2024, when it soared 347.47%.
- Cybin's Assets stood at $75.5 million in 2021, then sank by 40.77% to $44.7 million in 2022, then surged by 113.11% to $95.3 million in 2023, then soared by 90.48% to $181.5 million in 2024, then slipped by 0.7% to $180.2 million in 2025.
- The last three Assets figures came in at $180.2 million (Q1 2025), $181.5 million (Q4 2024), and $192.3 million (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 180.24 Mn |
| Dec 31, 2024 | 181.50 Mn |
| Sep 30, 2024 | 192.35 Mn |
| Jun 30, 2024 | 208.12 Mn |
| Mar 31, 2024 | 224.14 Mn |
| Dec 31, 2023 | 95.29 Mn |
| Sep 30, 2023 | 42.99 Mn |
| Jun 30, 2023 | 57.54 Mn |
| Feb 28, 2023 | 33.80 Mn |
| Dec 31, 2022 | 44.71 Mn |
| Sep 30, 2022 | 52.99 Mn |
| Dec 31, 2021 | 75.49 Mn |
| Sep 30, 2021 | 83.78 Mn |
| Jun 30, 2021 | 67.39 Mn |
| Mar 31, 2021 | 72.78 Mn |